Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Tuberous Sclerosis 4 Seizures 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sturge-Weber Syndrome 2 Neoplasms 2 Nausea 2 Marijuana Abuse 2 Lennox Gastaut Syndrome 2 Glioblastoma 2 Epilepsies, Myoclonic 2 Anxiety Disorders 2 Vomiting 1 Solid Tumor 1 Rectal Neoplasms 1 Parasomnias 1 Pancreatic Neoplasms 1 Pain 1 Multiple Myeloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Gallbladder Neoplasms 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cancer Pain 1

Interventions

pembrolizumab 11 Injections 11 Paclitaxel 10 Docetaxel 9 Cisplatin 8 Capecitabine 8 Nivolumab 7 Fluorodeoxyglucose F18 7 Bevacizumab 7 toripalimab 6 senaparib 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 tislelizumab 5 Cyclophosphamide 5 apatinib 4 Leucovorin 4 Ipilimumab 4 Gemcitabine 4 spartalizumab 3 pertuzumab 3 olaparib 3 fludarabine 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Oxaliplatin 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02255292 2014-10-02

A Study: Pure CBD as Single-agent for Solid Tumor.

Hadassah Medical Organization

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡